Every Form 4 that Azenta, Inc. (AZTA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AZTA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AZTA filings page.
Azenta, Inc. senior vice president and chief human resources officer Olga Pirogova reported a Form 4 transaction involving company common stock. On August 9, 2026, 1,085 shares were withheld by the company at $32.04 per share to satisfy tax withholding obligations upon vesting of equity awards, leaving her with 31,953 shares held directly. The company notes this was not a market sale of securities.
Azenta, Inc. executive Ephraim Starr, SVP, General Counsel & Secretary, purchased 335 shares of common stock on July 31, 2026 at $24.1676 per share. The shares were acquired under the Azenta, Inc. 2017 Employee Stock Purchase Plan, bringing his direct holdings to 68,728 shares, in a transaction exempt from Section 16(b) under Rule 16b-3(c).
Azenta, Inc. director William L. Cornog made an indirect open-market purchase of 10,000 shares of common stock on May 18, 2026 at a weighted average price of $16.38 per share. The shares were bought through trusts he beneficially owns and controls, bringing his indirect holdings to 19,703 shares.
Azenta, Inc. executive Starr Ephraim, SVP, General Counsel & Secretary, reported a tax-related share disposition. On May 15, 2026, 3,621 shares of common stock were delivered at $16.02 per share to satisfy withholding taxes tied to the vesting of 12,593 restricted stock units. After this tax-withholding transaction, the reporting person directly holds 68,393 shares of Azenta common stock.
Koffey Quentin reported acquisition or exercise transactions in this Form 4 filing.
Azenta, Inc. director Quentin Koffey received an annual grant of 5,663 shares of common stock under the company’s 2020 Equity Incentive Plan for Board service. No cash was paid for this award, which was valued at $215,000 using a $37.97 reference share price.
Following the grant, Koffey directly holds 10,698 shares. An additional 4,611,752 shares are reported as indirectly owned through entities he ultimately controls, with beneficial ownership disclaimed except for his pecuniary interest.
MARTIN WILLIAM E. III reported acquisition or exercise transactions in this Form 4 filing.
Azenta, Inc. granted President Multiomics William E. Martin III an award of 17,790 shares of common stock in the form of restricted stock units. The award is compensation under the company’s Equity Incentive Plan and no cash was paid to receive it.
The units vest over three years, with 33% vesting on April 18, 2027, 33% on April 18, 2028, and the remaining 33% on April 18, 2029. Following this grant, he directly holds 17,790 common shares linked to this award.
Azenta, Inc. director William L. Cornog filed an amended insider report to fix an administrative error in his equity holdings. The correction relates to a grant of 5,663 restricted stock units with a zero exercise price. After the correction, he is reported to beneficially own 9,703 derivative securities tied to Azenta common stock directly.
Azenta, Inc. director Tina S. Nova received an equity grant of 5,663 common shares under the company’s 2020 Equity Incentive Plan. The grant consisted of unrestricted shares, and no amount was paid upon grant. Following this award, she beneficially owns 15,772 Azenta common shares directly.
Azenta, Inc. reported an equity award to director William L. Cornog. On 02/05/2026, he received 5,663 restricted stock units (RSUs), each representing one share of Azenta common stock. The RSUs were granted at $0.00 under the company’s 2020 Equity Incentive Plan, with no cash paid at grant.
The units are fully vested upon grant, but settlement of the shares is deferred. Cornog elected to receive the underlying common stock at the later of his reaching age 65 or his separation from service with the company. After this grant, he beneficially owns 5,663 derivative securities directly.
Azenta director Martin Madaus received 5,663 restricted stock units on February 5, 2026 under the company’s 2020 Equity Incentive Plan. Each unit represents one share of Azenta common stock and was granted at no cost to him.
The units are fully vested on grant, but Madaus elected to defer settlement until the later of reaching age 65 or leaving the company. Following this award, he beneficially owns 9,703 derivative securities in the form of restricted stock units held directly.
Azenta director Dipal Doshi reported a stock grant from the company. On February 5, 2026, Doshi received 5,663 shares of Azenta common stock as a grant of unrestricted shares under the Company’s 2020 Equity Incentive Plan at a reported price of $27.85 per share. No cash was paid for this award, and Doshi now directly owns 9,703 common shares following the transaction.
Azenta, Inc. director Frank Casal reported receiving a grant of 7,243 shares of Azenta common stock on February 5, 2026 under the company’s 2020 Equity Incentive Plan. According to the filing, no cash was paid for this unrestricted share award.
After this grant, Casal beneficially owns 21,803 Azenta common shares, held directly. The transaction is reported as an acquisition of non-derivative securities and reflects routine equity-based compensation for a board member.
Azenta, Inc. director Erica McLaughlin received a grant of 5,663 shares of Azenta common stock on February 5, 2026. The shares are unrestricted and were granted under the company’s 2020 Equity Incentive Plan, with no cash paid for the grant. Following this award, she directly holds 22,521 Azenta common shares.
Azenta, Inc. director Robyn C. Davis received a grant of 5,663 restricted stock units on Azenta common stock on February 5, 2026. Each unit represents one share of common stock and was granted at a price of $0. The units are fully vested upon grant.
Davis elected to defer settlement of these units until the later of reaching age 65 or separating from service with the company. After this award, Davis beneficially owns 23,662 derivative securities in the form of restricted stock units, granted under Azenta’s 2020 Equity Incentive Plan.
Azenta, Inc. (AZTA) reported an equity award to its President and CEO, John Marotta. On 11/24/2025 he received a grant of 122,269 restricted stock units (RSUs) of Azenta common stock at a price of $0.00 per unit, recorded as an acquisition of non-derivative securities. Following this grant, he beneficially owns 217,268.78 shares of common stock.
The RSU award was sized by dividing a target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting, with 33-1/3% of the units scheduled to vest each year, beginning on November 24, 2026.
Azenta, Inc. (AZTA) executive Lawrence Y. Lin reported an equity award of company stock. On 11/24/2025, the EVP, CFO and Treasurer received a grant of 36,681 restricted stock units (RSUs) of Azenta common stock at a price of $0.00 per unit. Following this grant, he beneficially owns 79,655 shares of Azenta common stock in total, held directly.
The RSUs are subject to time-based vesting and are scheduled to vest in three equal annual installments of 33-1/3% each year, beginning on November 24, 2026. The number of RSUs granted was calculated by dividing a target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date.
Azenta, Inc. (AZTA) reported an equity compensation grant to one of its senior executives. On November 24, 2025, the company granted 16,303 restricted stock units (RSUs) of its common stock to its SVP and Chief Human Resources Officer, Olga Pirogova, with no cash paid upon grant and a stated price of $0.00 per unit.
The filing states that the number of RSUs was determined by dividing the target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting, with 33 1/3% vesting each year beginning on November 24, 2026. Following this grant, the reporting person beneficially owns 33,038 shares of Azenta common stock.
Azenta, Inc. (AZTA) reported an equity award to one of its senior executives. On 11/24/2025, the company’s SVP and GM, Multiomics received 13,042 restricted stock units (RSUs) of Azenta common stock at a grant price of $0.00 per unit. After this grant, the executive beneficially owns 38,755 shares of Azenta common stock in total, held directly.
The filing explains that the RSU amount was calculated by dividing the target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting and will vest in three equal installments of 33 1/3% per year, starting on November 24, 2026.
Azenta, Inc. (AZTA) reported an equity award to a senior executive. On November 24, 2025, the company’s SVP, General Counsel & Secretary acquired 34,235 shares of common stock through a grant of restricted stock units (RSUs) at a price of $0.00 per share. Following this grant, the executive beneficially owns 72,014 shares of Azenta common stock in direct ownership.
The RSUs were granted based on a target award value divided by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting and will vest in three equal installments of 33-1/3% per year, beginning on November 24, 2026.
Azenta, Inc. (AZTA) reported that a company director filed an amended Form 4 to correct earlier reporting of share purchases in May 2025. The director bought 100 shares on May 16, 2025 at $26.50, 4,152 shares on May 19, 2025 at $26.98, and 2,748 shares on May 20, 2025 at $27.37, all coded as open‑market purchases (code "P").
The amendment fixes administrative errors in the original filing that had understated the director’s beneficial ownership after each trade. The corrected beneficially owned share totals are 18,895 after the first purchase, 23,047 after the second, and 25,795 after the third, replacing previously miscalculated figures of 14,855, 19,007, and 21,755 shares.
Azenta, Inc. (AZTA) director filing correction: This Form 4/A amends a prior Form 4 for director William L. Cornog to fix an administrative error in his reported share ownership. After a grant of 4,040 restricted stock units on 02/04/2025, the original filing incorrectly showed 4,040 shares beneficially owned. The corrected figure is 18,795 shares of common stock underlying restricted stock units held directly. The amendment does not reflect a new transaction, only an updated and higher beneficial ownership amount for the same grant.
Azenta, Inc. (AZTA) director Martin Madaus filed an amended Form 4 to correct a prior administrative error in his reported shareholdings. The original Form 4, filed on February 11, 2025, had miscalculated the number of shares beneficially owned after a grant of 4,040 shares. The amendment clarifies that the correct number of shares beneficially owned following the transaction is 11,445 shares, not 4,040. The derivative position is reported as restricted stock units with a conversion price of $0, directly owned. This change does not reflect a new transaction but a correction to previously reported ownership.
Azenta, Inc. (AZTA) executive Ginger Zhou, SVP and GM, Multiomics, reported an automatic tax-related share withholding. On 11/14/2025, 1,118 common shares were withheld at $29.75 per share to cover taxes tied to the vesting on November 15, 2025 of 4,582 restricted stock units. After this transaction, Zhou beneficially owned 25,713 Azenta common shares in direct form.
Azenta, Inc. (AZTA) senior vice president and chief human resources officer reported a Form 4 transaction involving company common stock. On 11/14/2025, 1,553 common shares were withheld at a price of $29.75 per share, coded as a tax-related transaction (Code F). This withholding covered taxes tied to the vesting on November 15, 2025 of 4,529 restricted stock units held by the insider. After this transaction, the reporting person beneficially owned 16,735 Azenta common shares, held directly.
Azenta, Inc. (AZTA) reported an insider equity transaction by its EVP, CFO and Treasurer, Lawrence Y. Lin. On 11/14/2025, 3,039 shares of common stock were withheld to cover tax obligations tied to the vesting of 10,566 restricted stock units on November 15, 2025. After this tax withholding event, the reporting person beneficially owned 42,974 shares of Azenta common stock directly. This filing reflects an administrative tax-related transaction rather than an open-market purchase or sale.
Azenta, Inc. (AZTA) president and CEO John Marotta reported a tax-related transaction involving 10,980 shares of common stock. On November 14, 2025, shares were withheld at a price of $29.75 per share to cover withholding taxes tied to the vesting of 27,872 restricted stock units on November 15, 2025. This Form 4 reflects an administrative share withholding for taxes rather than an open-market purchase or sale.
Azenta, Inc. (AZTA) reported an insider sale by an officer via an amended Form 4. The reporting person, SVP and CHRO, filed an amendment to include a Power of Attorney and to correct the transaction code to “S.”
The filing shows a sale of 1,085 shares of common stock at $28.54 on 08/12/2025, leaving 18,288 shares beneficially owned directly after the transaction. The amendment clarifies the sale code and formalizes signing authority; it does not change the reported share amounts.
Azenta, Inc. (AZTA) reported an amended Form 4 for its President and CEO, who is also a Director. The amendment corrects the transaction code to "P" for a purchase of 1,000 common shares at $25.99 on 06/02/2025. Following the transaction, the reporting person beneficially owned 107,295.78 shares, held directly.
The amendment also adds a Power of Attorney authorizing filings of Forms 3, 4, and 5 on the reporting person’s behalf.
Azenta, Inc. (AZTA) reported an amended Form 4 for a director reflecting a common stock purchase and administrative corrections. The filing shows the director acquired 12,000 common shares on 05/30/2025 at $26.65 per share. Following the transaction, the director beneficially owned 17,035 shares, held directly.
The amendment adds the Power of Attorney that was omitted from the original and corrects the transaction code previously reported as “A” to the correct code “P.”
Azenta, Inc. (AZTA) filed an amended Form 4 reporting an insider transaction by SVP and GM, Multiomics, Ginger Zhou. On 08/12/2025, a sale (transaction code S) of 1,085 shares of common stock was reported at a price of $28.54 per share.
Following the transaction, the reporting person beneficially owned 26,831 shares, held directly. The amendment also notes two administrative corrections: inclusion of a Power of Attorney that was omitted from the original filing on 08/13/2025, and correction of the transaction code from “D” to the correct code “S.”